| domain | high-confidence finding | quantitative detail or ontology suggestion | evidence level/source |
|---|---|---|---|
| Identity / synonyms | CHST3-related skeletal dysplasia comprises overlapping phenotypes historically labeled recessive Larsen syndrome, humero-spinal dysostosis, chondrodysplasia with multiple dislocations, and spondyloepiphyseal dysplasia with congenital joint dislocations / Omani type | MONDO/Orphanet/OMIM identifiers: require database validation; disease-level aggregated resource synthesis should be used rather than EHR-derived labels (pqac-00000001, pqac-00000002, pqac-00000003) | Human clinical genetics cohort + 2023 review + 2024 skeletal dysplasia reference (pqac-00000001, pqac-00000002, pqac-00000003) |
| Etiology / inheritance | Caused by biallelic pathogenic variants in CHST3; inheritance is autosomal recessive | Gene: CHST3; ontology suggestion: autosomal recessive inheritance term requires database validation; consanguinity reported in affected families (pqac-00000000, pqac-00000001, pqac-00000003) | Human clinical genetics evidence, strong (pqac-00000000, pqac-00000001, pqac-00000003) |
| Pathogenic variant classes | Reported variant classes include missense, nonsense/premature-termination, frameshift, and splice-site variants | 2008 cohort: 9 mutations across 8 alleles; examples include Y201X, F206X, R222W, L259P, c.1086delG; 2023 review lists c.590T>C p.Leu197Pro, c.603C>A p.Tyr201Ter, c.661C>T p.Arg221Cys, c.802G>T p.Glu268* (pqac-00000001, pqac-00000002) | Human molecular genetics, strong/moderate (pqac-00000001, pqac-00000002) |
| Core phenotype | Congenital multiple joint dislocations are the defining presentation | Presenting feature in 6/6 patients from the 2008 cohort; HPO suggestions: Congenital joint dislocation, Knee dislocation, Hip dislocation, Radial head dislocation, Clubfoot; exact HPO IDs require database validation (pqac-00000004) | Human cohort, strong (pqac-00000004) |
| Phenotype frequency: clubfoot | Clubfeet are very common | 6/6 (100%) in the 2008 cohort; HPO suggestion: Clubfoot, ID requires database validation (pqac-00000000, pqac-00000004) | Human cohort, strong (pqac-00000000, pqac-00000004) |
| Phenotype frequency: knee dislocation | Congenital knee dislocation is very common and can be associated with genu recurvatum | 6/6 (100%) knee dislocation; genu recurvatum reported in 50% in one evidence summary; HPO suggestions require database validation (pqac-00000000, pqac-00000004) | Human cohort, strong, with some phenotype granularity from article summary (pqac-00000000, pqac-00000004) |
| Phenotype frequency: hip involvement | Hip luxation/dislocation is common but not universal | 4/6 (67%) in the 2008 cohort; HPO suggestion: Hip dislocation, ID requires database validation (pqac-00000000, pqac-00000004) | Human cohort, strong (pqac-00000000, pqac-00000004) |
| Phenotype frequency: elbow/radial head | Radial head dislocation is highly characteristic | 6/6 (100%) radial head dislocation; associated distal humerus dysplasia reported radiographically (pqac-00000000, pqac-00000001) | Human cohort, strong (pqac-00000000, pqac-00000001) |
| Growth / stature | Prenatal-onset short stature is typical | Birth length 41.5-44 cm, below 3rd percentile; oldest reported adult height 134 cm in the 2008 cohort; HPO suggestion: Short stature, ID requires database validation (pqac-00000000, pqac-00000001) | Human cohort, strong (pqac-00000000, pqac-00000001) |
| Spine / progression | Progressive spinal disease is a major morbidity domain | Severe intervertebral disc degeneration, thoracic kyphosis/kyphoscoliosis, vertebral fusion, lumbar vertebral clefting, widened interpedicular distances reported; HPO suggestions require database validation (pqac-00000000, pqac-00000001) | Human cohort with longitudinal observations, strong (pqac-00000000, pqac-00000001) |
| Mobility / disability | Function declines over time due to progressive joint restriction and spinal disease | Loss of ambulation or need for crutches/wheelchair reported in patients aged 10.5-31 years in the 2008 cohort (pqac-00000000, pqac-00000004) | Human natural-history observation, moderate/strong (pqac-00000000, pqac-00000004) |
| Additional phenotype notes | Intelligence is typically normal; some facial features may be present but are not the principal diagnostic feature | Normal intellect reported; facial features described as small mouth/overfolded ears or resemblance to diastrophic dysplasia; cleft palate and myopia not observed in the cited cohort (pqac-00000001) | Human cohort, moderate (pqac-00000001) |
| Molecular mechanism | Disease results from CHST3 deficiency causing loss/reduction of chondroitin 6-O-sulfation | Fibroblast studies showed 4-5-fold reduction in DDi-6S, the 6-sulfated disaccharide product of chondroitin sulfate; ontology suggestion: glycosaminoglycan biosynthetic process / proteoglycan metabolic process terms require database validation (pqac-00000000, pqac-00000004) | Functional human-cell evidence, strong (pqac-00000000, pqac-00000004) |
| Pathophysiology interpretation | Joint dislocations likely reflect primary joint dysplasia rather than simple ligamentous laxity; extracellular matrix/proteoglycan abnormalities underlie skeletal malformation | Mechanistic interpretation supported by radiographic and biochemical findings; chondroitin sulfate sulfation defect implicated in cartilage/proteoglycan biology (pqac-00000001, pqac-00000002, pqac-00000003) | Human clinical + review synthesis, moderate (pqac-00000001, pqac-00000002, pqac-00000003) |
| Diagnostic clues | Diagnosis is suspected from congenital dislocations plus disproportionate short stature and characteristic radiographs, then confirmed by molecular testing of CHST3 | Radiographic clues: knee dislocation/misalignment, bifid distal humerus with radial head subluxation, vertebral clefting, widened interpedicular distances; confirmatory test: CHST3 sequencing in a skeletal dysplasia gene panel / exome context; exact testing guideline identifiers require database validation (pqac-00000001, pqac-00000003) | Human cohort + reference review, moderate/strong (pqac-00000001, pqac-00000003) |
| Differential diagnosis | Historically overlaps with recessive Larsen syndrome and humero-spinal dysostosis; broader differential includes other skeletal dysplasias with congenital dislocations | Differential list should include other glycosaminoglycan synthesis disorders and skeletal dysplasias with multiple dislocations; exact ontology/disease IDs require database validation (pqac-00000001, pqac-00000003) | Human clinical genetics + review synthesis, moderate (pqac-00000001, pqac-00000003) |
| Management | Management is supportive and orthopedic, with frequent need for surgical stabilization and long-term mobility support | “Most patients require multiple surgical stabilization procedures”; supportive devices include crutches/wheelchair in progressive cases; NCIT intervention terms require database validation (pqac-00000001, pqac-00000004) | Human cohort, moderate/strong (pqac-00000001, pqac-00000004) |
| Prognosis | Condition is chronic and progressive, with substantial musculoskeletal disability but survival data are not established in the cited evidence | Major burden: progressive arthritis, contractures, disc degeneration, kyphoscoliosis, impaired ambulation; life expectancy, mortality, and validated QoL metrics: data gap in available evidence (pqac-00000000, pqac-00000001) | Human cohort natural history, moderate; major prognosis data gaps remain (pqac-00000000, pqac-00000001) |
| Epidemiology / population | Ultra-rare Mendelian disorder with published families from multiple populations; robust prevalence/incidence estimates are lacking | Cases reported in Pakistani, Turkish, Indian, Arab/Omani and other populations; recurrent c.776T>C variant noted in later literature; prevalence/incidence and carrier frequency: data gap in available evidence (pqac-00000002, pqac-00000003) | Review/reference-level evidence, moderate; epidemiology limited (pqac-00000002, pqac-00000003) |
| Environmental factors | No established environmental or infectious cause is supported in the cited disease-specific evidence | Gene-environment interactions and protective environmental factors: no disease-specific evidence identified in cited sources (pqac-00000000, pqac-00000003) | Evidence gap statement based on available sources (pqac-00000000, pqac-00000003) |
| 2023 development | A 2023 authoritative review summarized CHST3 deficiency within diagnostic/prognostic applications of carbohydrate sulfotransferases and reaffirmed the skeletal dysplasia / multiple dislocation phenotype spectrum | Publication date: Oct 2023; review highlights CHST3 mutations in skeletal dysplasia, chondrodysplasia, and autosomal recessive multiple joint dislocations (pqac-00000002) | Recent review, moderate (pqac-00000002) |
| 2024 development | A 2024 fetal/perinatal skeletal dysplasia reference continues to classify CHST3-related disorders among autosomal recessive glycosaminoglycan-synthesis skeletal dysplasias with congenital dislocations | Publication date: Mar 2024; emphasizes recessive Larsen syndrome, humero-spinal dysostosis, and spondyloepiphyseal dysplasia Omani type within the CHST3 spectrum (pqac-00000003) | Recent expert reference, moderate (pqac-00000003) |
| Knowledge-base curation note | Best-supported assertions currently derive from small cohorts and expert reviews; identifiers and ontology IDs should be cross-checked directly in OMIM/Orphanet/HPO/MONDO before database ingestion | Mark all uncertain IDs as requiring database validation; strongest quantitative phenotype data in available evidence come from the six-patient 2008 cohort (pqac-00000000, pqac-00000004) | Curation guidance from evidence quality profile (pqac-00000000, pqac-00000004) |


*Table: This table summarizes high-confidence, knowledge-base-ready findings on CHST3-related skeletal dysplasia from the available cited evidence. It emphasizes the strongest cohort data, core mechanism, and current gaps that require direct database validation or newer primary sources.*